In re-examining condom labeling as
directed by Public Law 106-554, FDA identified developments in the
scientific research that would justify updating the labeling for
latex condoms to ensure the labeling provided the most accurate
information possible. This guidance document lists the issues
requiring special controls identified by FDA and describe labeling
measures that, if followed by manufacturers, will generally address
the issues requiring special controls associated with latex
condoms.
Statute at
Large: 21
Stat. 360 Name of Statute: null
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.